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ABSTRACT 
Naturally existing Chlorogenic acid (CGA) is an antioxidant-rich compound reported to act a 
chemopreventive agent by scavenging free radicals and suppressing cancer-causing 
mechanisms. Conversely, the compound's poor thermal and pH (neutral and basic) stability, 
poor solubility, and low cellular permeability have been a huge hindrance for it to exhibit its 
efficacy as a nutraceutical compound. Supposedly, encapsulation of CGA in chitosan 
nanoparticles (CNP), nano-sized colloidal delivery vector, could possibly assist in enhancing 
its antioxidant properties, in vitro cellular accumulation, and increase chemopreventive 
efficacy at a lower concentration. Hence, in this study, a stable, monodispersed, non-toxic CNP 
synthesized via ionic gelation method at an optimum parameter (600 µL of 0.5 mg/mL of 
chitosan and 200 µL of 0.7 mg/mL of tripolyphosphate), denoted as CNP°, was used to 
encapsulate CGA. Sequence of physicochemical analyses and morphological studies were 
performed to discern the successful formation of the CNP°-CGA hybrid. Antioxidant property 
(studied via DPPH (1,1-diphenyl-2-picrylhydrazyl) assay), in vitro antiproliferative activity of 
CNP°-CGA, and in vitro accumulation of fluorescently labeled (FITC) CNP°-CGA in cancer 
cells were evaluated. Findings revealed that successful formation of CNP°-CGA hybrid was 
reveled through an increase in particle size 134.44 ± 18.29 nm (polydispersity index (PDI) 0.29 
± 0.03) as compared to empty CNP°, 80.89 ± 5.16 nm (PDI 0.26 ± 0.01) with a maximal of 
12.04 μM CGA loaded per unit weight of CNP° using 20 µM of CGA. This result correlated 
with Fourier-Transform Infrared (FTIR) spectroscopic analysis, transmission Electron 
Microscopy (TEM) and field emission scanning (FESEM) electron microscopy, and ImageJ 
evaluation. The scavenging activity of CNP°-CGA (IC50 5.2 ± 0.10 µM) were conserved and 
slightly higher than CNP° (IC50 6.4±0.78 µM). An enhanced cellular accumulation of 
fluorescently labeled CNP°-CGA in the human renal cancer cells (786-O) as early as 30 min 
and increased time-dependently were observed through fluorescent microscopic visualization 
and flow cytometric assessment. A significant concentration-dependent antiproliferation 
activity of encapsulated CGA was achieved at IC50 of 16.20 µM as compared to CGA itself 
(unable to determine from the cell proliferative assay), implying that the competent delivery 
vector, chitosan nanoparticle, is able to enhance the intracellular accumulation, 
antiproliferative activity, and antioxidant properties of CGA at lower concentration as 
compared to CGA alone. 
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